Metabolic syndrome: definitions and controversies
Open accessThe DOI matches its Crossref record; 157 of the 159 references it cites were found in a registry or an index.
Abstract
Metabolic syndrome (MetS) is a complex disorder defined by a cluster of interconnected factors that increase the risk of cardiovascular atherosclerotic diseases and diabetes mellitus type 2. Currently, several different definitions of MetS exist, causing substantial confusion as to whether they identify the same individuals or represent a surrogate of risk factors. Recently, a number of other factors besides those traditionally used to define MetS that are also linked to the syndrome have been identified. In this review, we critically consider existing definitions and evolving information, and conclude that there is still a need to develop uniform criteria to define MetS, so as to enable comparisons between different studies and to better identify patients at risk. As the application of the MetS model has not been fully validated in children and adolescents as yet, and because of its alarmingly increasing prevalence in this population, we suggest that diagnosis, prevention and treatment in this age group should better focus on established risk factors rather than the diagnosis of MetS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352 · cited 2×
“International Diabetes Federation (IDF) criteria (2005) [5]”
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698 · cited 1×
“NHANES 1988-1994 [143] 8,814 23.”
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 1×
“Cellular oxidative stress/renin-angiotensin-aldosterone system and MetS Emerging evidence suggests that nitric oxide (NO), inflammatory and oxidative stress also play important roles in the pathophysiology of MetS hypertension and DMT2 [94,95].”
BackgroundThe metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033 · cited 8×
“Currently used criteria to define MetS Historically, Reaven was the first to put forward the concept of ‘syndrome X’, (which he later renamed MetS), hypothesizing that it was a central feature in the development of CHD and DMT2, mainly through target tissue resistance to insulin action [1].”
BackgroundResultInfluentialCardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760 · cited 1×
“Several epidemiological studies have confirmed the increased risk of CVD in individuals with MetS, independently of the diagnostic criteria used [32-39].”
BackgroundSilencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949 · cited 1×
“Antagomirs (cholesterol conjugated antisense oligonucleotides) which target and silence miRNAs, as evidenced by hepatic miR-122 blockade in vivo [109], have already been successfully tested in a phase I clinical trial.”
BackgroundBanting lecture 1988. Role of insulin resistance in human disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,811
Obesity and the Metabolic Syndrome in Children and Adolescents
Weiss, R., Dziura, J., Burgert, T. S., Tamborlane, W. V., Taksali, S. E., Yeckel, C. W., Allen, K., Lopes, M., Savoye, M., Morrison, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031049 · Cited by 3,459
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Stress and disorders of the stress system
Chrousos, G. P. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.106 · Cited by 3,215 · cited 1×
“These hormonal alterations may lead to reactive insulin hypersecretion, and increasing visceral obesity and sarcopenia, resulting to dyslipidemia, hypertension and DMT2 [83].”
BackgroundSelf-citationThe Metabolic Syndrome and Cardiovascular Risk
Mottillo, S., Filion, K. B., Genest, J., Joseph, L., Pilote, L., Poirier, P., Rinfret, S., Schiffrin, E. L., & Eisenberg, M. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.034 · Cited by 3,009 · cited 1×
“5-fold increase in all-cause mortality [40].”
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689 · cited 2×
“Evidence from both human [111,112] and animal studies [113,114] suggests that the nutritional, hormonal, and metabolic environment of the mother, as well as the early postnatal environment, may permanently reprogram the structure and physiology of the offspring toward the development of metabolic disease, in later lif…”
BackgroundSelf-citationCook, S., Weitzman, M., Auinger, P., Nguyen, M., & Dietz, W. H. (2003) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.157.8.821 · Cited by 2,326 · cited 2×
“Later, findings from the Third National Health and Nutrition Examination Survey (NHANES), 1988-1994 [123] revealed that 4.”
BackgroundCornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Park, Y.-W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., & Heymsfield, S. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.427 · Cited by 2,074
The metabolic syndrome in children and adolescents ? an IDF consensus report
Zimmet, P., Alberti, K. G. M., Kaufman, F., Tajima, N., Silink, M., Arslanian, S., Wong, G., Bennett, P., Shaw, J., Caprio, S., et al. (2007) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00271.x · Cited by 2,013
Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death
Gami, A. S., Witt, B. J., Howard, D. E., Erwin, P. J., Gami, L. A., Somers, V. K., & Montori, V. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.032 · Cited by 1,888
Malik, S., Wong, N. D., Franklin, S. S., Kamath, T. V., L’Italien, G. J., Pio, J. R., & Williams, G. R. (2004) · Circulation · doi:10.1161/01.cir.0000140677.20606.0e · Cited by 1,848
Comment on the provisional report from the WHO consultation
(1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00059.x · Cited by 1,820
Endocrinology of the stress response
Charmandari, E., Tsigos, C., & Chrousos, G. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.67.040403.120816 · Cited by 1,799 · cited 1×
“eral fat accumulation as a result of chronic hypercortisolism, low growth hormone secretion and hypogonadism [80,81].”
BackgroundSelf-citationFord, E. S. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1769 · Cited by 1,710 · cited 1×
“Several epidemiological studies have confirmed the increased risk of CVD in individuals with MetS, independently of the diagnostic criteria used [32-39].”
BackgroundObesity in Young Men after Famine Exposure in Utero and Early Infancy
Ravelli, G.-P., Stein, Z. A., & Susser, M. W. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608122950701 · Cited by 1,647 · cited 1×
“Fetal/developmental basis of MetS The concept of fetal/developmental origin of MetS, since the first study linking intrauterine undernutrition with later obesity, continues to raise interest [110].”
BackgroundGrundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Cardiology in Review · doi:10.1097/01.crd.0000380842.14048.7e · Cited by 1,600
Sattar, N., Gaw, A., Scherbakova, O., Ford, I., O’Reilly, D. S. J., Haffner, S. M., Isles, C., Macfarlane, P. W., Packard, C. J., Cobbe, S. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000080897.52664.94 · Cited by 1,506 · cited 7×
“Currently used criteria to define MetS Historically, Reaven was the first to put forward the concept of ‘syndrome X’, (which he later renamed MetS), hypothesizing that it was a central feature in the development of CHD and DMT2, mainly through target tissue resistance to insulin action [1].”
ResultInfluentialAlexander, C. M., Landsman, P. B., Teutsch, S. M., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1210 · Cited by 1,475 · cited 1×
“Several epidemiological studies have confirmed the increased risk of CVD in individuals with MetS, independently of the diagnostic criteria used [32-39].”
BackgroundGrundy, S. M. (2011) · Atlas of Atherosclerosis and Metabolic Syndrome · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,223
Obesity and the Metabolic Syndrome in Developing Countries
Misra, A., & Khurana, L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1595 · Cited by 1,219 · cited 2×
“8% in male urban North Indians to 42% in female urban Iranians [27].”
BackgroundVgontzas, A. N., Papanicolaou, D. A., Bixler, E. O., Hopper, K. D., Lotsikas, A. J., LIN, H., Kales, A., & Chrousos, G. P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.1151 · Cited by 1,199 · cited 1×
“Stress-related IL-6 hypersecretion plus adipose-tissue-generated inflammatory hypercytokinemia, as well as hypercortisolism, contribute to increased production of acute phase reactants and blood hypercoagulation, which have been recently recognized as components of MetS [84,85].”
BackgroundSelf-citationXu, J., Lloyd, D. J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., Vonderfecht, S., Hecht, R., Li, Y.-S., Lindberg, R. A., et al. (2009) · Diabetes · doi:10.2337/db08-0392 · Cited by 1,151
Hu, G. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.10.1066 · Cited by 1,135 · cited 1×
“Several epidemiological studies have confirmed the increased risk of CVD in individuals with MetS, independently of the diagnostic criteria used [32-39].”
Backgroundde Ferranti, S. D., Gauvreau, K., Ludwig, D. S., Neufeld, E. J., Newburger, J. W., & Rifai, N. (2004) · Circulation · doi:10.1161/01.cir.0000145117.40114.c7 · Cited by 1,123
American College of Endocrinology Position Statement on the Insulin Resistance Syndrome
Einhorn, D. (2003) · Endocrine Practice · doi:10.4158/ep.9.s2.5 · Cited by 1,066 · cited 1×
“(2003) [142]”
McNeill, A. M., Rosamond, W. D., Girman, C. J., Golden, S. H., Schmidt, M. I., East, H. E., Ballantyne, C. M., & Heiss, G. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.385 · Cited by 1,054 · cited 1×
“Several epidemiological studies have confirmed the increased risk of CVD in individuals with MetS, independently of the diagnostic criteria used [32-39].”
BackgroundIdentification and characterization of metabolically benign obesity in humans
Stefan, N. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1609 · Cited by 1,049 · cited 1×
“Obesity/insulin resistance and MetS Although not all overweight or obese individuals are metabolically disturbed, the majority are IR [69-71].”
BackgroundErvin, R. B. (2009) · PubMed · Cited by 1,000
The metabolic syndrome: prevalence in worldwide populations
Cameron, A. J., Shaw, J. E., & Zimmet, P. Z. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.005 · Cited by 1,000
Laaksonen, D. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf145 · Cited by 916 · cited 1×
“It has previously been demonstrated that definitions like that of the WHO, which imposes as a prerequisite the presence of impaired fasting glucose (IFG) and/or IGT, confer a higher risk than the NCEP:ATPIII and IDF definitions, which consider elevated fasting plasma glucose as an essential, but not required component…”
BackgroundThe Effects of Diet on Inflammation
Giugliano, D., Ceriello, A., & Esposito, K. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.052 · Cited by 842 · cited 1×
“In particular, the three components of atherogenic dyslipidemia (increased low-density lipoprotein (LDL), decreased HDL and high blood triglyceride concentrations) are individually associated with a cardiovascular risk [29], while IR significantly increases the risk of developing DMT2, although approximately 25% of in…”
BackgroundThe Metabolic Syndrome as Predictor of Type 2 Diabetes
Lorenzo, C., Okoloise, M., Williams, K., Stern, M. P., & Haffner, S. M. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3153 · Cited by 803 · cited 1×
“However, recent studies have shown that the IDF and NCEP: ATPIII definitions of MetS predicted DMT2 at least as well as the WHO definition [58,59].”
ResultGrundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000111245.75752.c6 · Cited by 718 · cited 3×
“Blood Institute (AHA/NHLBI) criteria (2004) [6]”
BackgroundMethodLongitudinal Study on Pubertal Insulin Resistance
Goran, M. I., & Gower, B. A. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2444 · Cited by 712 · cited 1×
“More importantly, none of the MetS definitions consider the influences of growth and puberty, for instance the ‘normal’ insulin resistance in puberty [135,136], the changes in fat and fat-free mass and the changes in growth and sex steroid secretion.”
BackgroundDiabetes mellitus : a fundamental and clinical text
LeRoith, D., Taylor, S. I., & Olefsky, J. M. (2004) · Cited by 699
Zhu, S., Wang, Z., Heshka, S., Heo, M., Faith, M. S., & Heymsfield, S. B. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.4.743 · Cited by 682 · cited 7×
“Clinical implications for pediatric MetS MetS as a concept was originally developed to identify adults at a greatest risk for CVD and DMT2, however, the application of this model has not yet been fully validated in children and adolescents.”
BackgroundInfluentialHunt, K. J., Resendez, R. G., Williams, K., Haffner, S. M., & Stern, M. P. (2004) · Circulation · doi:10.1161/01.cir.0000140762.04598.f9 · Cited by 662
Intrauterine Growth Retardation Leads to the Development of Type 2 Diabetes in the Rat
Simmons, R. A., Templeton, L. J., & Gertz, S. J. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2279 · Cited by 638 · cited 1×
“Evidence from both human [111,112] and animal studies [113,114] suggests that the nutritional, hormonal, and metabolic environment of the mother, as well as the early postnatal environment, may permanently reprogram the structure and physiology of the offspring toward the development of metabolic disease, in later lif…”
BackgroundChrousos, G. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801278 · Cited by 636 · cited 2×
“Stress-related IL-6 hypersecretion plus adipose-tissue-generated inflammatory hypercytokinemia, as well as hypercortisolism, contribute to increased production of acute phase reactants and blood hypercoagulation, which have been recently recognized as components of MetS [84,85].”
BackgroundSelf-citationA Comparison of the Prevalence of the Metabolic Syndrome Using Two Proposed Definitions
Ford, E. S., & Giles, W. H. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.575 · Cited by 616 · cited 1×
“NHANES 1988-1994 [144] 8,608 23.”
The Metabolic Syndrome in Overweight Hispanic Youth and the Role of Insulin Sensitivity
Cruz, M. L., Weigensberg, M. J., Huang, T. T.-K., Ball, G., Shaibi, G. Q., & Goran, M. I. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031188 · Cited by 603 · cited 1×
“A variety of subsequent studies [120,123-131], using three or four criteria and variable definitions, revealed diversity in MetS prevalence in childhood.”
BackgroundComponents of the “Metabolic Syndrome” and Incidence of Type 2 Diabetes
Hanson, R. L., Imperatore, G., Bennett, P. H., & Knowler, W. C. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3120 · Cited by 590 · cited 1×
“The observation of the presence of MetS predicting the risk for DMT2 has also been examined by numerous studies; according to these reports, it is well accepted that the presence of MetS not only increases this risk, but is also highly predictive of new-onset DMT2 [6,42,53-55].”
BackgroundMetabolic Syndrome and Incident Diabetes
Ford, E. S., Li, C., & Sattar, N. (2008) · Diabetes Care · doi:10.2337/dc08-0423 · Cited by 577
Sleep apnea is a manifestation of the metabolic syndrome
Vgontzas, A. N., Bixler, E. O., & Chrousos, G. P. (2005) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2005.01.006 · Cited by 559 · cited 2×
“Visceral obesity/insulin resistance, determined by both genetic/constitutional and environmental factors, may be the principal culprit leading to sleep apnea, which, in turn, may accelerate these metabolic abnormalities, possibly through progressive elevation of stress hormones and cytokines such as noradrenaline, cor…”
BackgroundSelf-citationSmith, S. C., Jr. (2005) · The University of North Carolina at Chapel Hill University Libraries · doi:10.17615/x6gg-7674 · Cited by 546
Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study
Azizi, F., Salehi, P., Etemadi, A., & Zahedi-Asl, S. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00066-4 · Cited by 526 · cited 1×
“The trend for a higher prevalence of MetS with advancing age was similar to that observed in other populations [8,21-25].”
ResultFord, E. S. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.12.022 · Cited by 501 · cited 1×
“Several epidemiological studies have confirmed the increased risk of CVD in individuals with MetS, independently of the diagnostic criteria used [32-39].”
BackgroundPrevalence and Trends of a Metabolic Syndrome Phenotype Among U.S. Adolescents, 1999–2000
Duncan, G. E., Li, S. M., & Zhou, X.-H. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2438 · Cited by 500
Sattar, N., McConnachie, A., Shaper, A. G., Blauw, G. J., Buckley, B. M., de Craen, A. J., Ford, I., Forouhi, N. G., Freeman, D. J., Jukema, J. W., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60602-9 · Cited by 493 · cited 2×
“It should be noted however, that several studies amongst which the Casale Monferrato Study and PROSPER conducted in older people, failed to reveal an association between MetS and an increased risk of CVD [41,42].”
BackgroundResultHow Do MicroRNAs Regulate Gene Expression?
Jackson, R. J., & Standart, N. (2007) · Science's STKE · doi:10.1126/stke.3672007re1 · Cited by 475
FORD, E. S., LI, C., & ZHAO, G. (2010) · Journal of Diabetes · doi:10.1111/j.1753-0407.2010.00078.x · Cited by 471 · cited 1×
“which adopted a lower cut-off point for waist circumference, estimated a higher prevalence [14].”
BackgroundChildhood Obesity and Type 2 Diabetes Mellitus
Hannon, T. S., Rao, G., & Arslanian, S. A. (2005) · Pediatrics · doi:10.1542/peds.2004-2536 · Cited by 463 · cited 1×
“The increasing worldwide prevalence of childhood obesity and, in parallel, of DMT2 in the young [120,121], has highlighted the importance of MetS diagnosis in children and adolescents, as a state of high risk for progression to later disease.”
BackgroundInteractions of the circadian CLOCK system and the HPA-axis
Nader, N., Chrousos, G. P., & Kino, T. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.12.011 · Cited by 449 · cited 1×
“Interestingly, most of the metabolic phenotypes associated with dysregulation of the CLOCK system and the HPA axis overlap [93].”
BackgroundSelf-citationAdiponectin: a key adipocytokine in metabolic syndrome
Okamoto, Y., Kihara, S., Funahashi, T., Matsuzawa, Y., & Libby, P. (2006) · Clinical Science · doi:10.1042/cs20050182 · Cited by 432 · cited 1×
“Notably, adiponectin, an important adipocytokine that protects against the development of DMT2, hypertension, inflammation, and atherosclerotic vascular diseases, is decreased in individuals with visceral fat accumulation, and this may be causally related to MetS [73,74].”
BackgroundVgontzas, A. N., & Chrousos, G. P. (2002) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(01)00005-6 · Cited by 414 · cited 1×
“A possible association between visceral fat/insulin resistance, inflammatory cytokines, stress hormones, and sleep apnea has recently been suggested [89-91].”
BackgroundSelf-citationMicroRNAs: A new class of regulatory genes affecting metabolism
Krützfeldt, J., & Stoffel, M. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.009 · Cited by 408
Stewart, P. M., Boulton, A., Kumar, S., Clark, P. M. S., & Shackleton, C. H. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5538 · Cited by 398 · cited 1×
“In obesity global 11b-HSD1 activity, as measured by urinary corticosteroid metabolite analysis, is impaired [86,87], while selective 11bHSD1 inhibitors, are in development with promising results showing improvements in metabolic profile in rodents [88].”
MethodCardiometabolic Differences in Children Born After in Vitro Fertilization: Follow-Up Study
Ceelen, M., van Weissenbruch, M. M., Vermeiden, J. P. W., van Leeuwen, F. E., & Delemarre-van de Waal, H. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2432 · Cited by 384 · cited 1×
“Since in vitro fertilization (IVF) has been widely used, the possible effect of IVF (as a result of either intrauterine growth restriction or periconceptual manipulation of the blastocysts per se) in the incidence of MetS manifestations has been studied, producing conflicting results [117-119].”
ResultSowers, J. R., Whaley-Connell, A., & Epstein, M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00005 · Cited by 351 · cited 1×
“Furthermore, either use of angiotensin II type 1 receptor antagonists or genetic knockout of angiotensin II type 1 receptor are known to effectively attenuate lipid accumulation in the liver [99-105].”
Prevalence of the insulin resistance syndrome in obesity
Viner, R. M. (2005) · Archives of Disease in Childhood · doi:10.1136/adc.2003.036467 · Cited by 340 · cited 1×
“More importantly, none of the MetS definitions consider the influences of growth and puberty, for instance the ‘normal’ insulin resistance in puberty [135,136], the changes in fat and fat-free mass and the changes in growth and sex steroid secretion.”
BackgroundGinsberg, H. N., & MacCallum, P. R. (2009) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4572.2008.00044.x · Cited by 331 · cited 1×
“In this regard, in a recent appraisal of MetS, the American Diabetes Association (ADA) in conjunction with the European Association for the Study of Diabetes, issued a joint statement raising concerns over the value of using MetS as a CVD risk marker and recommended that clinicians should evaluate and treat all CVD ri…”
BackgroundIntrauterine Programming of Adult Body Composition1
Gale, C. R., Martyn, C. N., Kellingray, S., Eastell, R., & Cooper, C. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7155 · Cited by 318 · cited 1×
“Evidence from both human [111,112] and animal studies [113,114] suggests that the nutritional, hormonal, and metabolic environment of the mother, as well as the early postnatal environment, may permanently reprogram the structure and physiology of the offspring toward the development of metabolic disease, in later lif…”
BackgroundRenin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance
Cooper, S. A., Whaley-Connell, A., Habibi, J., Wei, Y., Lastra, G., Manrique, C., Stas, S., & Sowers, J. R. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00522.2007 · Cited by 317 · cited 1×
“Furthermore, either use of angiotensin II type 1 receptor antagonists or genetic knockout of angiotensin II type 1 receptor are known to effectively attenuate lipid accumulation in the liver [99-105].”
Deepa, M., Farooq, S., Datta, M., Deepa, R., & Mohan, V. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.658 · Cited by 307 · cited 2×
“This increase with age continues up to the sixth decade; however, different studies have estimated a variable prevalence after the sixth or seventh decades, probably as individuals most susceptible to obesity-related mortality have already died [22,24,26].”
BackgroundResultMetabolic Syndrome in Normal-Weight Americans
St-Onge, M.-P., Janssen, I., & Heymsfield, S. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2222 · Cited by 307
Effects of Aldosterone on the Vasculature
Schiffrin, E. L. (2006) · Hypertension · doi:10.1161/01.hyp.0000201443.63240.a7 · Cited by 303 · cited 1×
“Furthermore, either use of angiotensin II type 1 receptor antagonists or genetic knockout of angiotensin II type 1 receptor are known to effectively attenuate lipid accumulation in the liver [99-105].”
Pathophysiology and types of dyslipidemia in PCOS
Diamanti-Kandarakis, E., Papavassiliou, A. G., Kandarakis, S. A., & Chrousos, G. P. (2007) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.07.004 · Cited by 299 · cited 1×
“It should be noted however, that even lean individuals may develop features of MetS adding further to the complexity of its pathogenesis [28].”
BackgroundSelf-citationAngiotensin II-induced NADPH Oxidase Activation Impairs Insulin Signaling in Skeletal Muscle Cells
Wei, Y., Sowers, J. R., Nistala, R., Gong, H., Uptergrove, G. M.-E., Clark, S. E., Morris, E. M., Szary, N., Manrique, C., & Stump, C. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601320200 · Cited by 297 · cited 2×
“Elevation of angiotensin II can induce IR via reactive oxygen species (ROS) production in various tissues, including vascular smooth muscle and skeletal muscle in patients with MetS [96,98].”
BackgroundMagnussen, C. G., Koskinen, J., Chen, W., Thomson, R., Schmidt, M. D., Srinivasan, S. R., Kivimäki, M., Mattsson, N., Kähönen, M., Laitinen, T., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.940809 · Cited by 291 · cited 2×
“This new information is further supported by recently published data from the Bogalusa Heart Study and the Cardiovascular Risk in Young Finns [141].”
MethodPresence of metabolic cardiovascular syndrome in obese children
Csábi, G., Török, K., Jeges, S., & Molnár, D. (2000) · European Journal of Pediatrics · doi:10.1007/pl00013812 · Cited by 289 · cited 1×
“A variety of subsequent studies [120,123-131], using three or four criteria and variable definitions, revealed diversity in MetS prevalence in childhood.”
BackgroundThe renin-angiotensin-aldosterone system, glucose metabolism and diabetes
Giacchetti, G., Sechi, L. A., Rilli, S., & Carey, R. M. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.02.003 · Cited by 267 · cited 2×
“Elevation of angiotensin II can induce IR via reactive oxygen species (ROS) production in various tissues, including vascular smooth muscle and skeletal muscle in patients with MetS [96,98].”
BackgroundChen, W., Srinivasan, S. R., Elkasabany, A., & Berenson, G. S. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010069 · Cited by 267 · cited 1×
“Since the first publication of MetS in children, in 1999, [122], a growing interest emerged investigating MetS prevalence and the potential utility of this diagnosis, as well as therapeutic interventions in adolescents fulfilling it.”
BackgroundWaist circumference for the screening of the metabolic syndrome in children
Moreno, L., Pineda, I., Rodriguez, G., Fleta, J., Sarria, A., & Bueno, M. (2002) · Acta Paediatrica · doi:10.1111/j.1651-2227.2002.tb02825.x · Cited by 266 · cited 1×
“A variety of subsequent studies [120,123-131], using three or four criteria and variable definitions, revealed diversity in MetS prevalence in childhood.”
BackgroundHanley, A. J. G., Karter, A. J., Williams, K., Festa, A., D’Agostino, R. B., Wagenknecht, L. E., & Haffner, S. M. (2005) · Circulation · doi:10.1161/circulationaha.105.559633 · Cited by 266 · cited 1×
“However, recent studies have shown that the IDF and NCEP: ATPIII definitions of MetS predicted DMT2 at least as well as the WHO definition [58,59].”
ResultMetabolic Syndrome and Risk of Acute Myocardial Infarction
Mente, A., Yusuf, S., Islam, S., McQueen, M. J., Tanomsup, S., Onen, C. L., Rangarajan, S., Gerstein, H. C., & Anand, S. S. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.053 · Cited by 262
Aldosterone and Vascular Inflammation
Brown, N. J. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.095489 · Cited by 256 · cited 1×
“Furthermore, either use of angiotensin II type 1 receptor antagonists or genetic knockout of angiotensin II type 1 receptor are known to effectively attenuate lipid accumulation in the liver [99-105].”
Waist circumference for the screening of the metabolic syndrome in children
Moreno, L. A., Pineda, I., Rodrı́guez, G., Fleta, J., Sarría, A., & Bueno, M. (2002) · Acta Paediatrica · doi:10.1080/08035250216112 · Cited by 253
Kensara, O. A., Wootton, S. A., Phillips, D. I., Patel, M., Jackson, A. A., & Elia, M. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.5.980 · Cited by 251 · cited 1×
“Evidence from both human [111,112] and animal studies [113,114] suggests that the nutritional, hormonal, and metabolic environment of the mother, as well as the early postnatal environment, may permanently reprogram the structure and physiology of the offspring toward the development of metabolic disease, in later lif…”
BackgroundIntrauterine Programming of Adult Body Composition
Gale, C. R. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.267 · Cited by 251
Serum Uric Acid Is a Determinant of Metabolic Syndrome in a Population-Based Study
ONAT, A., UYAREL, H., HERGENC, G., KARABULUT, A., ALBAYRAK, S., SARI, I., YAZICI, M., & KELES, I. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.02.014 · Cited by 244 · cited 11×
“This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. presence of IR or its surrogates, impaired glu…”
BackgroundInfluentialInstability in the Diagnosis of Metabolic Syndrome in Adolescents
Goodman, E., Daniels, S. R., Meigs, J. B., & Dolan, L. M. (2007) · Circulation · doi:10.1161/circulationaha.106.669994 · Cited by 242 · cited 1×
“It was found that, though metabolic risk factor clustering was consistent, the categorical diagnosis of MetS was not stable during adolescence [138], including both gain and loss of diagnosis.”
BackgroundKahn, S. E., Prigeon, R. L., Schwartz, R. S., Fujimoto, W. Y., Knopp, R. H., Brunzell, J. D., & Porte, D. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.2.354s · Cited by 235 · cited 1×
“FFAs also reduce insulin sensitivity in muscle by inhibiting insulin-mediated glucose uptake and increase fibrinogen and PAI-1 production [9,79].”
BackgroundObesity‐Related Sleepiness and Fatigue: The Role of the Stress System and Cytokines
VGONTZAS, A. N., BIXLER, E. O., & CHROUSOS, G. P. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.023 · Cited by 232
Self-citationChen, W., Bao, W., Begum, S., Elkasabany, A., Srinivasan, S. R., & Berenson, G. S. (2000) · Diabetes · doi:10.2337/diabetes.49.6.1042 · Cited by 229
Metabolic Syndrome as a Predictor of All-Cause and Cardiovascular Mortality in Type 2 Diabetes
Bruno, G., Merletti, F., Biggeri, A., Bargero, G., Ferrero, S., Runzo, C., Prina Cerai, S., Pagano, G., & Cavallo-Perin, P. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2689 · Cited by 224
Sex differences in inflammatory markers: what is the contribution of visceral adiposity?
Cartier, A., Côté, M., Lemieux, I., Pérusse, L., Tremblay, A., Bouchard, C., & Després, J.-P. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27030 · Cited by 216 · cited 1×
“In particular, women have higher concentrations of inflammatory markers, such as high sensitivity C reactive protein (hs-CRP), compared to men, attributed possibly to their increased accumulation of subcutaneous and/or visceral fat [60,61].”
BackgroundGoodman, E., Dolan, L. M., Morrison, J. A., & Daniels, S. R. (2005) · Circulation · doi:10.1161/01.cir.0000161957.34198.2b · Cited by 213 · cited 1×
“A variety of subsequent studies [120,123-131], using three or four criteria and variable definitions, revealed diversity in MetS prevalence in childhood.”
BackgroundOverweight and obesity in Portugal: national prevalence in 2003–2005
Do Carmo, I., Dos Santos, O., Camolas, J., Vieira, J., Carreira, M., Medina, L., Reis, L., Myatt, J., & Galvão‐Teles, A. (2008) · Obesity Reviews · doi:10.1111/j.1467-789x.2007.00422.x · Cited by 206
Role of microRNAs in obesity and the metabolic syndrome
Heneghan, H. M., Miller, N., & Kerin, M. J. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00659.x · Cited by 203 · cited 1×
“Although the exact mechanism of action remains to be elucidated, miRNAs may regulate cellular gene expression at the transcriptional or post-transcriptional level, by suppressing translation of protein-coding genes, or cleaving target messenger RNAs (mRNAs) to induce their degradation, through imperfect pairing with t…”
BackgroundAdiponectin: A Key Player in Obesity Related Disorders
Matsuzawa, Y. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791208893 · Cited by 203 · cited 1×
“Notably, adiponectin, an important adipocytokine that protects against the development of DMT2, hypertension, inflammation, and atherosclerotic vascular diseases, is decreased in individuals with visceral fat accumulation, and this may be causally related to MetS [73,74].”
BackgroundLambert, M., Paradis, G., O'Loughlin, J., Delvin, E. E., Hanley, J. A., & Levy, E. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802694 · Cited by 193 · cited 1×
“A variety of subsequent studies [120,123-131], using three or four criteria and variable definitions, revealed diversity in MetS prevalence in childhood.”
BackgroundResistin and visfatin: regulators of insulin sensitivity, inflammation and immunity
Stofkova, A. (2010) · Endocrine Regulations · doi:10.4149/endo_2010_01_25 · Cited by 191 · cited 1×
“In particular, visfatin has been suggested to exert insulin-mimicking/sensitizing effects but can also contribute to the inflammatory processes by triggering cytokine production and nuclear factor B (NF- B) activation, while vice versa visfatin secretion is upregulated in response to proinflammatory cytokines [78].”
BackgroundHigh prevalence of metabolic syndrome in Mexico
Aguilar-Salinas, C. A., Rojas, R., Gómez-Pérez, F. J., Valles, V., Rı́os-Torres, J. M., Franco, A., Olaiz, G., Rull, J. A., & Sepúlveda, J. (2004) · Archives of Medical Research · doi:10.1016/j.arcmed.2003.06.006 · Cited by 190 · cited 1×
“The trend for a higher prevalence of MetS with advancing age was similar to that observed in other populations [8,21-25].”
ResultChrousos, G. P., & Kino, T. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04988.x · Cited by 186
Self-citationEarly life nutrition and metabolic programming
Fernandez‐Twinn, D. S., & Ozanne, S. E. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05798.x · Cited by 174 · cited 1×
“Evidence from both human [111,112] and animal studies [113,114] suggests that the nutritional, hormonal, and metabolic environment of the mother, as well as the early postnatal environment, may permanently reprogram the structure and physiology of the offspring toward the development of metabolic disease, in later lif…”
BackgroundNeprilysin, obesity and the metabolic syndrome
Standeven, K. F., Hess, K., Carter, A. M., Rice, G. I., Cordell, P. A., Balmforth, A. J., Lu, B., Scott, D. J., Turner, A. J., Hooper, N. M., et al. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.227 · Cited by 174
Blendea, M. C., Jacobs, D., Stump, C. S., McFarlane, S. I., Ogrin, C., Bahtyiar, G., Stas, S., Kumar, P., Sha, Q., Ferrario, C. M., et al. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00402.2004 · Cited by 171 · cited 1×
“Increased production of reactive oxygen species (ROS) in numerous tissues, including skeletal muscle and cardiovascular tissues, has been linked (amongst others) to activation of the renin-angiotensin-aldosterone system [96,97], which is also implicated in the development of IR [98].”
BackgroundZabetian, A., Hadaegh, F., & Azizi, F. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.12.001 · Cited by 169 · cited 1×
“2% respectively) [20].”
Valsamakis, G., Anwar, A., Tomlinson, J. W., Shackleton, C. H. L., McTernan, P. G., Chetty, R., Wood, P. J., Banerjee, A. K., Holder, G., Barnett, A. H., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032240 · Cited by 160 · cited 1×
“In obesity global 11b-HSD1 activity, as measured by urinary corticosteroid metabolite analysis, is impaired [86,87], while selective 11bHSD1 inhibitors, are in development with promising results showing improvements in metabolic profile in rodents [88].”
MethodBrambilla, P., Lissau, I., Flodmark, C., Moreno, L. A., Widhalm, K., Wabitsch, M., & Pietrobelli, A. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803581 · Cited by 159 · cited 2×
“Obesity has been defined as the 85th to 97th percentile of BMI or waist circumference, while accordingly, a variety of cut-off percentiles have been used for blood pressure, triglycerides, HDL, insulin and glucose [133].”
BackgroundThe Metabolic Syndrome in Australia: Prevalence using four definitions
Cameron, A. J., Magliano, D. J., Zimmet, P. Z., Welborn, T., & Shaw, J. E. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.02.002 · Cited by 158 · cited 1×
“This increase with age continues up to the sixth decade; however, different studies have estimated a variable prevalence after the sixth or seventh decades, probably as individuals most susceptible to obesity-related mortality have already died [22,24,26].”
Background50th Anniversary of Aldosterone
Williams, J. S., & Williams, G. H. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030490 · Cited by 150 · cited 1×
“Furthermore, either use of angiotensin II type 1 receptor antagonists or genetic knockout of angiotensin II type 1 receptor are known to effectively attenuate lipid accumulation in the liver [99-105].”
Sakka, S. D., Loutradis, D., Kanaka‐Gantenbein, C., Margeli, A., Papastamataki, M., Papassotiriou, I., & Chrousos, G. P. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.09.049 · Cited by 142
Self-citationObesity and the Metabolic Syndrome
Keller, K. B., & Lemberg, L. (2003) · American Journal of Critical Care · doi:10.4037/ajcc2003.12.2.167 · Cited by 136
In Vitro Fertilization Improves Childhood Growth and Metabolism
Miles, H. L., Hofman, P. L., Peek, J., Harris, M. A., Wilson, D., Robinson, E. M., Gluckman, P. D., & Cutfield, W. S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2465 · Cited by 133 · cited 1×
“Since in vitro fertilization (IVF) has been widely used, the possible effect of IVF (as a result of either intrauterine growth restriction or periconceptual manipulation of the blastocysts per se) in the incidence of MetS manifestations has been studied, producing conflicting results [117-119].”
ResultThe role of fat topology in the risk of disease
Matsuzawa, Y. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.243 · Cited by 126 · cited 1×
“Central obesity is thought to be an early step, as visceral adipose tissue secretes a variety of bioactive substances termed adipocytokines, such as leptin, resistin, tumor necrosis factor a (TNFa), interleukin-6 (IL-6), and angiotensin II which induce IR, along with plasminogen activator inhibitor 1 (PAI-1), which is…”
BackgroundMetabolic Syndrome and Early-Onset Coronary Artery Disease
Iribarren, C., Go, A. S., Husson, G., Sidney, S., Fair, J. M., Quertermous, T., Hlatky, M. A., & Fortmann, S. P. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.070 · Cited by 124 · cited 1×
“One major point of note was that the risk of CHD when three components of MetS were present did not appear to be greater than the risk of individual components such as DMT2 and hypertension, and this was in agreement with other reports [50,51].”
ResultOnat, A., Can, G., Hergenç, G., Yazıcı, M., Karabulut, A., & Albayrak, S. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803552 · Cited by 112 · cited 11×
“This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. presence of IR or its surrogates, impaired glu…”
BackgroundInfluentialAthyros, V. G., Mikhailidis, D. P., Papageorgiou, A. A., Didangelos, T., Ganotakis, E. S., Symeonidis, A. N., Daskalopoulou, S. S., Kakafika, A. I., & Elisaf, M. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904x5599 · Cited by 103
Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population
Athyros, V. G., Ganotakis, E. S., Τζιόμαλος, Κ., Papageorgiou, A. A., Anagnostis, P. G., Griva, T., Kargiotis, K., Mitsiou, E. K., Karagiannis, A. I., Mikhailidis, D. P., et al. (2010) · Current Medical Research and Opinion · doi:10.1185/03007991003590597 · Cited by 101 · cited 9×
“A recent meta-analysis suggested that the WHO definition was associated with a slightly greater risk than the NCEP:ATPIII definition [43].”
BackgroundInfluentialHarzallah, F., Alberti, H., & Khalifa, F. B. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01866.x · Cited by 101 · cited 9×
“A recent meta-analysis suggested that the WHO definition was associated with a slightly greater risk than the NCEP:ATPIII definition [43].”
BackgroundInfluentialFetal origins of the metabolic syndrome
Xita, N., & Tsatsoulis, A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05658.x · Cited by 96 · cited 1×
“Evidence from both human [111,112] and animal studies [113,114] suggests that the nutritional, hormonal, and metabolic environment of the mother, as well as the early postnatal environment, may permanently reprogram the structure and physiology of the offspring toward the development of metabolic disease, in later lif…”
BackgroundTargeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes
Gathercole, L., & Stewart, P. M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.03.060 · Cited by 89 · cited 1×
“In obesity global 11b-HSD1 activity, as measured by urinary corticosteroid metabolite analysis, is impaired [86,87], while selective 11bHSD1 inhibitors, are in development with promising results showing improvements in metabolic profile in rodents [88].”
MethodHillier, T. A., Fagot‐Campagna, A., Eschwège, É., Vol, S., Cailleau, M., & Balkau, B. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyi281 · Cited by 81 · cited 1×
“No matter which criteria are used, the prevalence of MetS is high and rising in all western societies, probably as a result of the obesity epidemic [10-12].”
BackgroundOxidative Retinal Products and Ocular Damages in Diabetic Patients
Grattagliano, I., Vendemiale, G., Boscia, F., Ferrari, T. M., Cardia, L., & Altomare, E. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00059-8 · Cited by 79 · cited 1×
“Cellular oxidative stress/renin-angiotensin-aldosterone system and MetS Emerging evidence suggests that nitric oxide (NO), inflammatory and oxidative stress also play important roles in the pathophysiology of MetS hypertension and DMT2 [94,95].”
BackgroundOnat, A., & Hergenç, G. (2010) · Metabolism · doi:10.1016/j.metabol.2010.04.018 · Cited by 78
Mineralocorticoid Receptor Antagonists and the Metabolic Syndrome
Tirosh, A., Garg, R., & Adler, G. K. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0126-2 · Cited by 72 · cited 1×
“Furthermore, either use of angiotensin II type 1 receptor antagonists or genetic knockout of angiotensin II type 1 receptor are known to effectively attenuate lipid accumulation in the liver [99-105].”
The effect of puberty on insulin resistance in obese children
Pilia, S., Casini, M. R., Foschini, M. L., Minerba, L., Musiu, M. C., Marras, V., Civolani, P., & Loche, S. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346475 · Cited by 72 · cited 1×
“Further to these changes, it has been shown that in obese children, insulin resistance (as measured by the homeostasis model assessmentinsulin resistance (HOMA-IR) index) increases progressively across Tanner stages and is higher in all pubertal stages than in normal weight children [137].”
BackgroundPrevalence of Metabolic Syndrome in an Adult Urban Population of the West of Iran
Sharifi, F., Mousavinasab, S. N., Saeini, M. R., & Dinmohammadi, M. (2009) · Experimental Diabetes Research · doi:10.1155/2009/136501 · Cited by 70 · cited 9×
“A recent meta-analysis suggested that the WHO definition was associated with a slightly greater risk than the NCEP:ATPIII definition [43].”
BackgroundInfluentialOnat, A., Hergenç, G., Bulur, S., Uğur, M., Küçükdurmaz, Z., & Can, G. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.12.066 · Cited by 68 · cited 11×
“This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. presence of IR or its surrogates, impaired glu…”
BackgroundInfluentialMetabolic Syndrome as a Cardiovascular Disease Risk Factor: Patients Evaluated in Primary Care
Cabré, J.-J., Martín‐Luján, F., Costa, B., Piñol, J. L., Jl, L., Ortega, Y., Basora, J., Justel, M. B., Solà, R., Daniel, J., et al. (2008) · BMC Public Health · doi:10.1186/1471-2458-8-251 · Cited by 62
Hollman, G., & Kristenson, M. (2007) · European Journal of Cardiovascular Nursing · doi:10.1016/j.ejcnurse.2007.05.003 · Cited by 62 · cited 1×
“No matter which criteria are used, the prevalence of MetS is high and rising in all western societies, probably as a result of the obesity epidemic [10-12].”
BackgroundFiúza, M., Cortez‐Dias, N., Martins, S. R., & Belo, A. (2008) · PubMed · Cited by 60
Deletion of angiotensin II type I receptor reduces hepatic steatosis
Nabeshima, Y., Tazuma, S., Kanno, K., Hyogo, H., & Chayama, K. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.01.018 · Cited by 60 · cited 1×
“Furthermore, either use of angiotensin II type 1 receptor antagonists or genetic knockout of angiotensin II type 1 receptor are known to effectively attenuate lipid accumulation in the liver [99-105].”
The metabolic syndrome and nonfatal ischemic heart disease; a population-based study
Nabipour, I., Amiri, M., Imami, S. R., Jahfari, S. M., Shafiei, E., Nosrati, A., Iranpour, D., & Soltanian, A. R. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.06.017 · Cited by 60 · cited 1×
“One major point of note was that the risk of CHD when three components of MetS were present did not appear to be greater than the risk of individual components such as DMT2 and hypertension, and this was in agreement with other reports [50,51].”
ResultOnat, A., Hergenç, G., Karabulut, A., Türkmen, S., Doğan, Y., Uyarel, H., Can, G., & Sansoy, V. (2006) · Preventive Medicine · doi:10.1016/j.ypmed.2006.04.005 · Cited by 44 · cited 11×
“This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. presence of IR or its surrogates, impaired glu…”
BackgroundInfluentialTwo measures of insulin sensitivity provided similar information in a U.S. population
Bravata, D. M., Wells, C. K., Concato, J., Kernan, W. N., Brass, L. M., & Gulanski, B. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.05.001 · Cited by 44
Onat, A., Uğur, M., Can, G., Yüksel, H., & Hergenç, G. (2009) · Nutrition · doi:10.1016/j.nut.2009.05.019 · Cited by 39 · cited 1×
“In particular, women have higher concentrations of inflammatory markers, such as high sensitivity C reactive protein (hs-CRP), compared to men, attributed possibly to their increased accumulation of subcutaneous and/or visceral fat [60,61].”
BackgroundCsászár, A., Kékes, E., Abel, T., Papp, R., Kiss, I., & Balogh, S. (2006) · Blood Pressure · doi:10.1080/08037050600772284 · Cited by 37 · cited 1×
“The trend for a higher prevalence of MetS with advancing age was similar to that observed in other populations [8,21-25].”
ResultTeramura, M., Emoto, M., Araki, T., Yokoyama, H., Motoyama, K., Shinohara, K., Mori, K., Koyama, H., Shoji, T., Inaba, M., et al. (2007) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e505 · Cited by 37 · cited 7×
“Currently used criteria to define MetS Historically, Reaven was the first to put forward the concept of ‘syndrome X’, (which he later renamed MetS), hypothesizing that it was a central feature in the development of CHD and DMT2, mainly through target tissue resistance to insulin action [1].”
ResultInfluentialGoodman, E., Li, C., Tu, Y., Ford, E. S., Sun, S. S., & Huang, T. T. ‐. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.04.045 · Cited by 31 · cited 1×
“A second, more recent study from the same group, examined the stability of three alternative models of MetS factor structure across three developmental changes [139].”
BackgroundGenetic links between diabetes mellitus and coronary atherosclerosis
Ordovás, J. M. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0020-9 · Cited by 29 · cited 1×
“The great variation in susceptibility and age of onset in individuals with a very similar risk profile, suggests a major interaction between genetic and environmental factors [68].”
BackgroundMa, W.-Y., Li, H., Hung, C. S., Lin, M., Chiu, F., Lin, C.-H., Shih, S., Chuang, L., & Wei, J. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.06.020 · Cited by 29 · cited 9×
“A recent meta-analysis suggested that the WHO definition was associated with a slightly greater risk than the NCEP:ATPIII definition [43].”
BackgroundInfluentialOnat, A., Özhan, H., Erbilen, E., Albayrak, S., Küçükdurmaz, Z., Can, G., Keleş, İ., & Hergenç, G. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.03.054 · Cited by 27 · cited 11×
“This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. presence of IR or its surrogates, impaired glu…”
BackgroundInfluentialThe relationship between visfatin and metabolic syndrome in postmenopausal women
Kim, J., Kim, S.-H., Im, J., & Lee, D. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.05.002 · Cited by 24 · cited 1×
“Moreover, newly recognized adipocytokines such as visfatin, as well as enzymes expressed in adipose tissue, such as neprilysin, and growth factors, like fibroblast growth factor 21, an important regulator of glucose and lipid metabolism, are currently under investigation regarding their role in the pathogenesis of Met…”
BackgroundGermani, D., Puglianiello, A., & Cianfarani, S. (2008) · Cardiovascular Diabetology · doi:10.1186/1475-2840-7-14 · Cited by 19 · cited 1×
“Evidence from both human [111,112] and animal studies [113,114] suggests that the nutritional, hormonal, and metabolic environment of the mother, as well as the early postnatal environment, may permanently reprogram the structure and physiology of the offspring toward the development of metabolic disease, in later lif…”
BackgroundVgontzas, A. N., & Chrousos, G. P. (2002) · Sleep Medicine · doi:10.1016/s1389-9457(02)00067-9 · Cited by 16 · cited 1×
“A possible association between visceral fat/insulin resistance, inflammatory cytokines, stress hormones, and sleep apnea has recently been suggested [89-91].”
BackgroundSelf-citationAssessment of metabolic profile in a clinical setting
Pervanidou, P., Kanaka‐Gantenbein, C., & Chrousos, G. P. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000241669.24923.8d · Cited by 11 · cited 1×
“Similarly to adults, no general consensus exists regarding the definition of MetS in children and adolescents [132].”
BackgroundSelf-citationTimóteo, A. T., Santos, R., Lima, S., Mamede, A., Fernandes, R., & Ferreira, R. (2009) · PubMed · Cited by 6
Timóteo, A. T., SANTOS, R., Lima, S., Mamede, A., Fernandes, R., & Ferreira, F. (2006) · European Journal of Echocardiography · doi:10.1016/s1525-2167(06)60734-8 · Cited by 1
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s · cited 2×
“World Health Organization criteria (1998) [2]”
BackgroundInfluential
Research works printed but not linked: 1
- Pervanidou P, Kanaka-Gantenbein C, Lazopoulou N, Karamouzis I, Bastaki D, Julius A, Chrousos GP: Inconsistency of Metabolic Syndrome Diagnosis and Correlation of Morning Serum Cortisol Concentrations with Stability of Metabolic Abnormalities in Obese Children and Adolescents. Hormone Research. 2009, 72 (Suppl 3): 283.
Cited by
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Duman, R. S., Aghajanian, G. K., Sanacora, G., & Krystal, J. H. (2016) · Nature Medicine · doi:10.1038/nm.4050 · Cited by 1,750
The Definition and Prevalence of Obesity and Metabolic Syndrome
Engin, A. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-48382-5_1 · Cited by 1,180
Psoriasis and comorbid diseases
Takeshita, J., Grewal, S., Langan, S. M., Mehta, N. N., Ogdie, A., Van Voorhees, A. S., & Gelfand, J. M. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.07.064 · Cited by 1,145
“Metabolic syndrome Metabolic syndrome is generally defined by the presence of a combination of central obesity, hypertension, insulin resistance, and dyslipidemia.(88) Studies have found metabolic syndrome and its individual components tobemoreprevalent amongpatientswith than without psoriasis in both adult and pediat…”
Ranasinghe, P., Mathangasinghe, Y., Jayawardena, R., Hills, A. P., & Misra, A. (2017) · BMC Public Health · doi:10.1186/s12889-017-4041-1 · Cited by 746
“However, it is generally accepted that no matter which criteria are used, the prevalence of MetS is high and rising in most counties as a result of the obesity epidemic [41].”
BackgroundSantana-Gálvez, J., Cisneros-Zevallos, L., & Jacobo-Velázquez, D. (2017) · Molecules · doi:10.3390/molecules22030358 · Cited by 721
“Its components include dyslipidemia (elevated plasma total cholesterol, low-density lipoproteins (LDL), and triglycerides, and low levels of high-density lipoproteins (HDL)), high blood pressure, high fasting blood glucose levels, insulin resistance, chronic proinflammatory and prothrombotic states, non-alcoholic fatt…”
BackgroundInfluential
Metadata
- Authors
- Kassi, E., Pervanidou, P., Kaltsas, G., & Chrousos, G.
- Affiliations
- National and Kapodistrian University of Athens (GR)
- Corresponding author
- Chrousos, George
- Venue
- BMC Medicine
- Published
- 2011-05-05
- Volume
- 9
- Issue
- 1
- Pages
- 48-48
- ISSN
- 1741-7015 (ISSN-L)
- PMC
- PMC3115896
- OpenAlex
- W2120336033
- Cited by
- 1,565
- References
- 159
- Citations by year
- 2026: 61 · 2025: 138 · 2024: 185 · 2023: 150 · 2022: 139 · 2021: 157 · 2020: 103 · 2019: 80 · 2018: 76 · 2017: 84 · 2016: 80 · 2015: 91 · 2014: 88 · 2013: 76 · 2012: 43
- FWCI
- 9.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- metabolic syndrome, diagnostic criteria, metabolic syndrome definitions, cardiovascular risk, type 2 diabetes, atherosclerosis, children and adolescents, risk factors, prevention and treatment
- MeSH terms
- Coronary Artery Disease, Diabetes Mellitus, Type 2, Humans, Prevalence, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.